Viewing Study NCT04525261


Ignite Creation Date: 2025-12-24 @ 11:59 AM
Ignite Modification Date: 2025-12-30 @ 8:12 PM
Study NCT ID: NCT04525261
Status: COMPLETED
Last Update Posted: 2023-11-29
First Post: 2020-07-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Natural History of Patients With Inherited Retinal Diseases Due to Mutations in RPE65 Gene
Sponsor: University of Campania Luigi Vanvitelli
Organization:

Study Overview

Official Title: Natural History of Patients With Inherited Retinal Diseases Due to Mutations in RPE65 Gene
Status: COMPLETED
Status Verified Date: 2023-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: RPE65-NHS
Brief Summary: Rationale:

In preparation for treatment with gene therapy, this study is being conducted in order to investigate the natural history of Inherited Retinal Dystrophies (IRDs) due to mutations in RPE65 gene. Such a study will help identify suitable patients for therapeutic intervention.

Methodology:

This is a multicenter retrospective, descriptive chart review study designed to assess retinal structure and function in subjects with IRDs due to mutation in RPE65 gene by visual acuity, visual field measurements, Optical Coherence Tomography (OCT), and a number of other vision-related assessments.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: